Dupixent from Sanofi and Regeneron Pharmaceuticals is expected to gain approval for COPD, which would significantly increase its sales
https://seekingalpha.com/news/4085383-sanofi-regeneron-dupixent-set-large-gains-likely-copd-approval
Dupixent from Sanofi and Regeneron Pharmaceuticals is expected to gain approval for COPD, which would significantly increase its sales
https://seekingalpha.com/news/4085383-sanofi-regeneron-dupixent-set-large-gains-likely-copd-approval
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.